Navigation Links
Medicsight Launches ColonCAD(TM) Online CTC Platform
Date:6/29/2009

NEW YORK, June 29 /PRNewswire-FirstCall/ -- Medicsight PLC, a subsidiary of MGT Capital Investments, Inc. (NYSE AMEX: MGT) and an industry leader in the development of Computer-Aided Detection (CAD) and image analysis software that assists radiologists in the early detection of disease, is pleased to announce the launch of its online product, MedicRead(TM) 3.0 Colon. This online offering makes the benefits of Medicsight's ColonCAD software truly accessible to all radiologists for the first time.

MedicRead(TM) 3.0 Colon is Medicsight's advanced visualization platform that includes the Company's ColonCAD(TM) software. MedicRead(TM) 3.0 Colon allows radiologists to read computer tomography (CT) scans for the detection of colonic polyps, which may be the precursors of colon cancer. MedicRead(TM) 3.0 Colon can be downloaded from the Internet at www.medicsight.com and will be sold as a total solution with either a single list price or available on a monthly installment basis over 12 months.

Allan Rowley, Chief Executive of Medicsight, commented, "The launch of the online MedicRead 3.0 Colon platform provides us with an additional distribution channel for our exciting ColonCAD(TM) software. The MedicRead 3.0 Colon platform is currently the only visualization workstation for virtual colonoscopy that can be accessed and downloaded via the Internet. This broad access allows us to reach a broader user base and allows the international radiology community the ability to take advantage of the clinical benefits of our ColonCAD."

Access to Medicsight's ColonCAD(TM) software is currently available through its partners' advanced 3D visualization platforms. As part of Medicsight's ongoing commitment to radiologists and to improving the early detection of colorectal cancer, Medicsight has developed MedicRead 3.0 Colon. This is a competitively priced, standalone, CTC visualization workstation that incorporates the latest version of ColonCAD 4.0 as well as Medicsight's MedicServer(TM) technology. MedicRead 3.0 Colon offers a valuable centralized pre-processing platform that accepts DICOM CT image data from either the CT console or any PACS system.

A 30-day free trial version of the software can be downloaded from the Medicsight new website www.medicsight.com, allowing radiologists to experience the benefits of ColonCAD first-hand.

The new online application was showcased at the Medicsight booth at ESGAR 2009, which took place last week in Valencia, Spain.

Medicsight's ColonCAD technology has been approved for use in the European Union, China, Canada and Brazil. MedicRead 3.0 Colon is not currently available for sale in the United States.

About MGT Capital Investments, Inc.

MGT Capital Investments, Inc. is a technology holding company that focuses on investments in the global healthcare information technology market. The Company has two subsidiaries, Medicsight PLC and Medicexchange Ltd.

Medicsight PLC (AIM: MDST) is a UK-headquartered, research driven, leading developer of computer-aided detection (CAD) and image analysis software for the medical imaging market. The CAD software automatically highlights suspicious areas on computerized tomography (CT) scans of the colon and lung, helping radiologists to identify, measure and analyze potential disease and early indicators of disease. Medicsight's CAD software has been validated using one of the world's largest and most population diverse databases of verified patient CT scan data. Medicsight's ColonCAD(TM) and LungCAD(TM) software products are seamlessly integrated with the advanced 3D visualization workstations of several industry-leading imaging equipment partners.

Medicexchange Ltd. provides medical imaging professionals with a global web portal containing an online sales, jobs and information channel for diagnostic, treatment and surgery planning solutions. This combined with a variety of relevant clinical papers, training materials and content gives these professionals access to information and products that they otherwise would have difficulty accessing.

Additional information can be found at www.mgtci.com.

All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.


'/>"/>
SOURCE MGT Capital Investments, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Medicsight Announces Global Agreement With Alma IT Systems
2. CMS Decision - No Material Financial Impact to Medicsight
3. Medicsight PLC Provides Business Update
4. Medicsight PLC Restructures Management Team
5. MGT Capital Investments, Inc.: Failure to Satisfy a Continued Listing Rule Based on a Lack of Shareholder Meeting in 2008 and Medicsight Statement Regarding CMS Proposed Decision
6. Medicsight PLC Receives Additional Information Request for FDA 510(k) Clearance
7. Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis
8. Medicsight Announces New Global Marketing Partnership with Ziosoft Unveiled at RSNA 2008
9. Medicsight ColonCAD Technology Successfully Identified Cancer in 100% of Patients Included in Data Presented at ESGAR 2008
10. Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser
11. MGT Capital Investments, Inc. is Delighted with the Announcement of Medicsights Commercial Agreement with Toshiba PACS Division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2016)... ... February 07, 2016 , ... HealthSmart Holdings, ... and organizations with the tools and information to lower the costs, and increase ... the cost of providing employee healthcare benefits by as much as 22%:, + ...
(Date:2/7/2016)... Scottsdale, AZ (PRWEB) , ... February 07, 2016 ... ... & Neck and Facial Plastics, has added Kybella® to his medical and surgical ... is a newly approved FDA injectable medication used as a non-surgical alternative for ...
(Date:2/6/2016)... , ... February 06, 2016 ... ... 303-368-6225 , MEDIA ADVISORY: 5000 PERIOPERATIVE NURSES EXPECTED AT AORN SURGICAL CONFERENCE ... perioperative nurses in the world with an estimated 5000 perioperative nurses in ...
(Date:2/6/2016)... ... February 06, 2016 , ... US Sports Camps is ... (YUCC) . This event brings together top non-profit leaders, ultimate organizations, and coaches from ... Ultimate”. Valerio Iani, Bay Area Disc Program Director of Youth and Education, describes this ...
(Date:2/6/2016)... Viejo, CA (PRWEB) , ... February 06, 2016 , ... ... quickly and easily add warm color grades to their footage. A LUT is a ... every pixel's color to the corresponding color indicated by the table. By manipulating each ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016  Patients in Alabama ... focused ultrasound (HIFU) therapy no longer have to travel out ... its partnership with Urology Centers of Alabama to ... FDA-cleared procedure for qualifying patients. Alabama ... in the treatment of prostate cancer using many different modalities. ...
(Date:2/5/2016)... 5, 2016 Aethlon Medical, Inc. (Nasdaq: AEMD ... CEO, will be presenting at Source Capital Group,s 2016 Disruptive ... at 2:15 p.m. ET on Wednesday, February 10, ... discussion taking place at 3:15 p.m. ET. http://www.aethlonmedical.com ... hour after the conclusion of the live event. The panel ...
(Date:2/5/2016)... 5, 2016 Dehaier Medical Systems Ltd. ... "Company"), which develops, markets and sells medical devices ... China and international markets, today announced ... to concentrate the Company,s resources to develop its ... and to focus more on its major businesses. ...
Breaking Medicine Technology: